Delayed Radiation Myelopathy in a Child With Hodgkin Lymphoma and ARTEMIS Mutation.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
01 04 2021
01 04 2021
Historique:
received:
06
01
2020
accepted:
29
03
2020
pubmed:
29
4
2020
medline:
20
5
2021
entrez:
29
4
2020
Statut:
ppublish
Résumé
The authors present a case of delayed radiation myelopathy in a 12-year-old girl with Hodgkin lymphoma and Artemis mutation. This is the first of such a case presented in the literature.
Identifiants
pubmed: 32341262
pii: 00043426-202104000-00029
doi: 10.1097/MPH.0000000000001815
doi:
Substances chimiques
DNA-Binding Proteins
0
DCLRE1C protein, human
EC 3.1.-
Endonucleases
EC 3.1.-
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e404-e407Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Ermoian RP, Fogh SE, Braunstein S, et al. Pizzo PA, Poplack DG. General principles of radiation oncology. Principles and Practice of Pediatric Oncology, 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2016:362–383.
Rogers LR. Neurologic complications of radiation. Continuum (Minneap Minn). 2012;18:343–354.
Kupeli S, Bicakci K, Sezgin G, et al. Evaluation of late cerebral vascular complications in cranially irradiated pediatric cancer patients with magnetic resonance angiography. Tumori. 2018;104:381–387.
Gibbs IC, Patil C, Gerszten PC, et al. Delayed radiation-induced myelopathy after spinal radiosurgery. Neurosurgery. 2009;64(2 suppl):A67–A72.
Varan A, Büyükpamukçu M, Ersoy F, et al. Malignant solid tumors associated with congenital immunodeficiency disorders. Pediatr Hematol Oncol. 2004;21:441–451.
Cowan MJ, Gennery AR. Radiation-sensitive severe combined immunodeficiency: the arguments for and against conditioning before hematopoietic cell transplantation—what to do? J Allergy Clin Immunol. 2015;136:1178–1185.
Dvorak CC, Cowan MJ. Radiosensitive severe combined immunodeficiency disease. Immunol Allergy Clin North Am. 2010;30:125–142.
Roifman CM Rich RR, Fleisher TA, Shearer WT, Schroder HW, Frew AJ, Weyand CM. Primary T-cell immunodeficiencies. Clinical Immunology Principles and Practice, 5th ed. China: Elsevier; 2019:489–508. e1.
Stray-Pedersen A, Sorte HS, Samarakoon P, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017;139:232–245.
Kirkpatrick JP, van der Kogel AJ, Schultheiss TE. Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys. 2010;76(suppl 3):S42–S49.
Kadir T, Sarica FB, Ozgur K, et al. Delayed radiation myelopathy: differential diagnosis with positron emission tomography/computed tomography examination. Asian J Neurosurg. 2012;7:206–209.
Okada S, Okeda R. Pathology of radiation myelopathy. Neuropathology. 2001;21:247–265.
Wara WM, Phillips TL, Sheline GE, et al. Radiation tolerance of the spinal cord. Cancer. 1975;35:1558–1562.
Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122.
Rock JP, Ryu S, Yin FF, et al. The evolving role of stereotactic radiosurgery and stereotactic radiation therapy for patients with spine tumors. J Neurooncol. 2004;69:319–334.
Jellinger K, Sturm KW. Delayed radiation myelopathy in man. Report of twelve necropsy cases. J Neurol Sci. 1971;14:389–408.
Basso-Ricci S, Zanini M. Delayed myelitis caused by radiation in patients treated for Hodgkin’s disease. Minerva Med. 1984;75:2679–2682.
Staff NP, Grisold A, Grisold W, et al. Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol. 2017;81:772–781.